Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αb-crystallin

Nature

Volumn 494, Issue 7435, 2013, Pages 90-94

  Shao, Wei ^a   Zhang, Shu Zhen ^a   Tang, Mi ^a,b   Zhang, Xin Hua ^a   Zhou, Zheng ^a   Yin, Yan Qing ^a   Zhou, Qin Bo ^a   Huang, Yuan Yuan ^a   Liu, Ying Jun ^a   Wawrousek, Eric ^c   Chen, Teng ^d   Li, Sheng Bin ^d   Xu, Ming ^e   Zhou, Jiang Ning ^f   Hu, Gang ^b   Zhou, Jia Wei ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c NATIONAL EYE INSTITUTE   (United States)

^d MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^e UNIVERSITY OF CHICAGO   (United States)

^f University of Science and Technology of China   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA B CYSTALLIN; ALPHA CRYSTALLIN; DOPAMINE 2 RECEPTOR; QUINPIROLE; UNCLASSIFIED DRUG; CRYAB PROTEIN, MOUSE; NEUROPROTECTIVE AGENT;

AGING POPULATION; BRAIN; CELL ORGANELLE; DISEASE PREVALENCE; IMMUNE RESPONSE; MOLECULAR ANALYSIS; NEUROLOGY; TOXICITY;

ANIMAL CELL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; IMMUNOMODULATION; INNATE IMMUNITY; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SUBSTANTIA NIGRA; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; GENETICS; IMMUNOLOGY; INFLAMMATION; MALE; METABOLISM; MICROGLIA; PATHOLOGY;

MUS;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ALPHA-CRYSTALLIN B CHAIN; ANIMALS; ASTROCYTES; DOPAMINERGIC NEURONS; IMMUNITY, INNATE; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; NEUROPROTECTIVE AGENTS; QUINPIROLE; RECEPTORS, DOPAMINE D2; SUBSTANTIA NIGRA;

MLCS; MLOWN;

EID: 84874677592     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11748     Document Type: Article

References (33)

1. Bhat, R. & Steinman, L. Innate and adaptive autoimmunity directed to the central nervous system. Neuron 64, 123-132 (2009).
2. Ousman, S. S. et al. Protective andtherapeutic role for aB-crystallin in autoimmune demyelination. Nature 448, 474-479 (2007).
3. Langston, J. W., Ballard, P., Tetrud, J. W. & Irwin, I.Chronic Parkinsonismin humans due to a product of meperidine-analog synthesis. Science 219, 979-980 (1983).
4. Lucin, K. M. & Wyss-Coray, T. Immune activation in brain aging and neurodegeneration: too much or too little? Neuron 64, 110-122 (2009).
5. Seeman, P. et al. Human brain dopamine receptors in children and aging adults. Synapse 1, 399-404 (1987).
6. Kaasinen, V. et al. Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain. Neurobiol. Aging 21, 683-688 (2000).
7. Antonini, A. & Leenders, K. L. Dopamine D2 receptors in normal human brain: effect of age measured by positron emission tomography (PET) and [11C]-raclopride. Ann. NY Acad. Sci. 695, 81-85 (1993).
8. Zhang, Y. & Barres, B. A. Astrocyte heterogeneity: an underappreciated topic in neurobiology. Curr. Opin. Neurobiol. 20, 588-594 (2010).
9. Bal, A. et al. Evidence for D2 receptor mRNA expression by striatal astrocytes in culture: in situ hybridization and polymerase chain reaction studies. Brain Res. Mol. Brain Res. 23, 204-212 (1994).
10. Luo, X., Zhang, X., Shao, W., Yin, Y. & Zhou, J. Crucial roles of MZF-1 in the transcriptional regulation of apomorphine-induced modulation of FGF-2 expression in astrocytic cultures. J. Neurochem. 108, 952-961 (2009).
11. Saijo, K. et al. A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137, 47-59 (2009).
12. Zhuo, L. et al. hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo. Genesis 31, 85-94 (2001).
13. Iwaki, T., Kume-Iwaki, A., Liem, R. K. & Goldman, J. E. aB-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain. Cell 57, 71-78 (1989).
14. Hagemann, T. L., Boelens, W. C., Wawrousek, E. F. & Messing, A. Suppression of GFAP toxicity by aB-crystallin in mouse models of Alexander disease. Hum. Mol. Genet. 18, 1190-1199 (2009).
15. Jackson-Lewis, V. & Przedborski, S. Protocol for the MPTP mouse model of Parkinson's disease. Nature Protocols 2, 141-151 (2007).
16. Rivest, S. Regulation of innate immune responses in the brain. Nature Rev. Immunol. 9, 429-439 (2009).
17. Saijo, K., Collier, J. G., Li, A. C., Katzenellenbogen, J. A. & Glass, C. K. An ADIOL-ERb-CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell 145, 584-595 (2011).
18. Saijo, K., Crotti, A. & Glass, C. K. Nuclear receptors, inflammation, and neurodegenerative diseases. Adv. Immunol. 106, 21-59 (2010).
19. Brady, J. P. et al. aB-crystallin in lens development and muscle integrity: a gene knockout approach. Invest. Ophthalmol. Vis. Sci. 42, 2924-2934 (2001).
20. Xu, M. et al. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 andD2 receptors. Neuron 19, 837-848 (1997).
21. Casper, K. B., Jones, K. & McCarthy, K. D. Characterization of astrocyte-specific conditional knockouts. Genesis 45, 292-299 (2007).
22. Cai, L. et al. Ethanol-induced neurodegeneration in NRSF/REST neuronal conditional knockout mice. Neuroscience 181, 196-205 (2011).
23. Kelly, M. A. et al. Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron 19, 103-113 (1997).
24. Drago, J. et al. Altered striatal function in a mutant mouse lacking D1A dopamine receptors. Proc. Natl Acad. Sci. USA 91, 12564-12568 (1994).
25. Ousman, S. S. et al. Protective andtherapeutic role for aB-crystallin in autoimmune demyelination. Nature 448, 474-479 (2007).
26. Li, A. et al. Apomorphine-induced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons. FASEB J. 20, 1263-1265 (2006).
27. Sauer, H., Rosenblad, C. & Bjorklund, A. Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. Natl Acad. Sci. USA 92, 8935-8939 (1995).
28. Menet, V. et al. Inactivation of the glial fibrillary acidic protein gene, but not that of vimentin, improves neuronal survival and neurite growth by modifying adhesion molecule expression. J. Neurosci. 21, 6147-6158 (2001).
29. Saura, J., Tusell, J. M. & Serratosa, J. High-yield isolation of murine microglia by mild trypsinization. Glia 44, 183-189 (2003).
30. Guo, H. et al. Apomorphine induces trophic factors that support fetal rat mesencephalic dopaminergic neurons in cultures. Eur. J. Neurosci. 16, 1861-1870 (2002).
31. Zhou, Q., Li, J., Wang, H., Yin, Y. & Zhou, J. Identification of nigral dopaminergic neuron-enriched genes in adult rats. Neurobiol. Aging 32, 313-326 (2011).
32. Dimberg, A. et al. aB-crystallin promotes tumor angiogenesis by increasing vascular survival during tube morphogenesis. Blood 111, 2015-2023 (2008).
33. Sauer, H. & Oertel, W. H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59, 401-415 (1994).